Literature DB >> 19951299

QT interval dispersion and cardiac sympathovagal balance shift in rats with acute ethanol withdrawal.

Seiko Shirafuji1, Jinyao Liu, Nanako Okamura, Kazuyuki Hamada, Tatsuya Fujimiya.   

Abstract

BACKGROUND: Dysregulation of autonomic nervous system function and impaired homogeneity of myocardial repolarization are 2 important mechanisms for the genesis of ventricular arrhythmias in nonalcoholic subjects. Our previous study suggested that acute ethanol withdrawal promoted the shift of cardiac sympathovagal balance toward sympathetic predominance and reduced the vagal tone, which were related to a higher incidence of ventricular arrhythmia and related death. However, the homogeneity of myocardial repolarization and its relation with the cardiac sympathovagal balance are unknown, especially in alcoholic subjects. The aim of the present study was to clarify these points.
METHODS: Male Wistar rats were treated with a continuous ethanol liquid diet for 49 days, and then subjected to 1-day withdrawal and 1-day withdrawal with 7-day carvedilol (can block the sympathetic nervous system completely via beta1, beta2, and alpha adrenergic receptors) pretreatment. The cardiac sympathovagal balance and homogeneity of myocardial repolarization were evaluated based on the heart rate variability (HRV) and QT interval dispersion (QTd: dynamic changes in QT interval duration).
RESULTS: The increase in QTd was observed only in rats at 1-day withdrawal, but not in nonalcoholic, continuous ethanol intake, and 1-day withdrawal with 7-day carvedilol pretreatment rats. At 1-day withdrawal, the low-frequency power/high-frequency power (LF/HF) ratio in HRV was elevated and correlated with the QTd. The increased QTd and elevated LF/HF ratio were normalized by the 7-day carvedilol pretreatment in rats at 1-day ethanol withdrawal.
CONCLUSIONS: In rats with an abrupt termination of the chronic continuous ethanol intake, the homogeneity of myocardial repolarization impaired and correlated with the cardiac sympathovagal balance. Carvedilol pretreatment is associated with a reduction in both the QTd and LF/HF ratio, raising the possibility that the cardiac sympathovagal balance shift may be responsible for the impaired homogeneity of myocardial repolarization, and that beta-blocker pretreatment may decrease the mortality risk during alcoholic withdrawal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19951299     DOI: 10.1111/j.1530-0277.2009.01085.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  6 in total

Review 1.  Neurochemical mechanisms of alcohol withdrawal.

Authors:  Howard C Becker; Patrick J Mulholland
Journal:  Handb Clin Neurol       Date:  2014

2.  QT dispersion in patients with pulmonary embolism.

Authors:  Necip Ermıs; Hilal Ermıs; Nazan Sen; Alper Kepez; Bilal Cuglan
Journal:  Wien Klin Wochenschr       Date:  2010-12-10       Impact factor: 1.704

3.  The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo.

Authors:  Kevin Sean Murnane; Osman F Guner; J Phillip Bowen; Kalyn M Rambacher; Nader H Moniri; Tyler J Murphy; Cedrick Maceo Daphney; Aboagyewaah Oppong-Damoah; Kenner C Rice
Journal:  Pharmacol Biochem Behav       Date:  2019-04-15       Impact factor: 3.533

4.  Multi-factorial causes of torsade de pointes in a hospitalised surgical patient.

Authors:  Prashanth Panduranga; Mohammed Al-Mukhaini; Mamatha P Rajarao
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

5.  Temporal changes in innate immune signals in a rat model of alcohol withdrawal in emotional and cardiorespiratory homeostatic nuclei.

Authors:  Kate Freeman; Anthony Brureau; Rajanikanth Vadigepalli; Mary M Staehle; Melanie M Brureau; Gregory E Gonye; Jan B Hoek; D Craig Hooper; James S Schwaber
Journal:  J Neuroinflammation       Date:  2012-05-24       Impact factor: 8.322

6.  Acute coronary ischemia during alcohol withdrawal: a case report.

Authors:  Chaturaka Rodrigo; Dhanesha Seneviratne Epa; Ganeshalingam Sriram; Saroj Jayasinghe
Journal:  J Med Case Rep       Date:  2011-08-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.